Sufyan Hussain, United Kingdom

Guy's and St Thomas' , King's College London Diabetes
Dr Sufyan Hussain is a Consultant Diabetes and Endocrine Physician at Guy’s and St Thomas Hospital and Honorary Senior Clinical Lecturer at King’s College London. He maintains a specialist interest in diabetes technology and in the clinical application of closed-loop systems. He graduated in medicine from the University of Cambridge and undertook his post-graduate clinical training in London teaching hospitals. He completed his PhD with Sir Professor Stephen Bloom at Imperial College London and was a visiting scholar at Joslin Diabetes Centre, Harvard Medical School. He was appointed as a Darzi fellow in Clinical Leadership where he worked on regional and national projects related to integrated care and digital health. He is the clinical expert lead for the National Institute of Clinical Excellence technology appraisal on hybrid-closed loop systems, contributes to national strategic and educational initiatives as an ABCD Diabetes Technology Network, NHSE London Diabetes Strategic Clinical Network and JDRF Scientific Advisory Committee member. He has 30 years personal experience of living with type 1 diabetes and is passionate about improving care for diabetes with technology.

Presenter of 1 Presentation

ORAL PRESENTATION SESSION

DEVELOPMENT OF AN INTERNATIONAL CONSENSUS STATEMENT AND PRACTICAL GUIDANCE ON OPEN-SOURCE AUTOMATED INSULIN DELIVERY (DO-IT-YOURSELF ARTIFICIAL PANCREAS SYSTEMS) FOR HEALTHCARE PROFESSIONALS

Abstract

Background and Aims

Despite increasing use of Open-Source Automated Insulin Delivery (OS-AID) systems and real-world outcomes demonstrating safety and efficacy, there is no professional guidance available for HCPs to support use or provide clarity on ethical and legal concerns. As a result, a lot of uncertainty remains in care teams around the world on how to support people with diabetes using OS-AID. Therefore, an international professional consensus statement and practical guidance review is urgently needed.

Methods

As part of the OPEN project, a steering committee comprising of HCPs (endocrinologists, educators, exercise physiologists and psychologists) with significant clinical experience in OS-AID and publication track record was formed to develop the guidance. An international group of clinicians across several global regions formed part of a larger HCP network and contributed to the wider consensus of this guidance using an online feedback system. Input was also provided by medico-legal experts.

Results

Since the initial meeting at ATTD 2020, the steering committee has met virtually over 12 times. A review strategy was devised (see figure) and up-to-date best practice guidance and consensus statement were drafted using a real-time collaboration tool. The current final version is being appraised by the wider HCP network and major professional diabetes organisations on a multinational level.

figure1-1.jpg

Conclusions

Our detailed consensus finds OS-AID satisfies the principles of medical ethics and there is sufficient observational data supporting its safety and efficacy. It provides best practice recommendations for HCPs. Furthermore, it highlights important recommendations for regulators and industry.

Hide